Evidence map

ReviewCureus2023

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Benefits Versus Risk.

Bains Jasleen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

31 papers cite it

2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36819350